| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |